Maolin Yu, Ph.D.

Senior DIRECTOR OF MEDICINAL CHEMISTRY

As Senior Director of Medicinal Chemistry, Maolin Yu oversees all of medicinal chemistry and DMPK activities and is a team member for CMC and drug product development.

Prior to Nirogy, Maolin joined Goldfinch Bio in 2017 and served as senior principal scientist. In his capacity, he helped build, led chemistry team and discovered GFB-887, a TRPC5 inhibitor that currently is in phase 2 clinical trial. Prior to that, Maolin joined Boehringer-Ingelheim Pharmaceutics in 2008, where he led cross department chemistry efforts and directly contributed to the advancement of multiple programs to clinic.

Maolin Holds a B.S. in Chemistry from Lanzhou University and a Ph.D. in Synthetic Organic Chemistry from University of Alberta. He was a postdoctoral research fellow at Columbia University.

Laura Crawford, Ph.D., DABT, RAC-Drugs

Scroll to Top

This website uses cookies to ensure you get the best experience on our website.

Vincent P. Sandanayaka, Ph.D.

FOUNDER

At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi, id est laborum et dolorum fuga. Et harum quidem rerum facilis est et expedita distinctio. Nam libero tempore, cum soluta nobis est eligendi optio cumque nihil impedit quo minus id quod maxime placeat facere possimus, omnis voluptas assumenda est, omnis dolor repellendus. Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet ut et voluptates repudiandae sint et molestiae non recusandae. Itaque earum rerum hic tenetur a sapiente delectus, ut aut reiciendis voluptatibus maiores alias consequatur aut perferendis doloribus asperiores repellat